In summary, Bondue's study hypothesized that chemerin appears to have anti-inflammatory properties, by acting on ChemR23 expressed by non-leukocytic cells (possibly lung endothelial cells), thereby dampening the inflammatory response promoted by the viral infection. Here, CMKLR1 is linked to viral infectious disease.